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Coronavirus disease 2019 in Italy: The Veneto model
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To the Editor—In a Viewpoint article in the Journal of the
American Medical Association (JAMA) regarding the third
novel coronavirus (SARS-CoV2) outbreak in Wuhan, China, in
December 2019, Drs Wu and McGoogan presented the key find-
ings in a large case series of 72,314 infected individuals, refining
the estimates in China to severe disease in 14% of cases and a
case-fatality rate of 2.3%.1 Among the total case records, only
889 (1%) were classified as asymptomatic (ie, lacking typical
symptoms including fever, dry cough, and fatigue), >5 times
lower than those observed in Italy.2 After February 21, 2020,
Italy became the hardest-hit country, with the highest death toll
of 17,127 (>5 times as much as China) and 135,586 confirmed
cases on April 7, 2020.
Recent evidence shows that 86% of all infections were undocu-
mented prior to the Wuhan shutdown on January 23, 2020, repre-
senting the infection source for 79% of documented cases.3 It has
now become evident that the percentage of mild or asymptomatic
cases in developed societies, such as China and Italy, prior to major
restrictions or control, was much higher than previously recog-
nized. Although challenging without strict containment measures,
Fig. 1. Timeline of number of tests for SARS-COV-2 per million people (dotted lines) and case fatality rate (solid lines) in Lombardia (blue) and Veneto (red).
Source: Italian Civil Protection and Ministry of Health.
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identification of these subjects may slow the spread of SARS-CoV2.
The cases of Veneto and Lombardia, contemporaneously affected
neighboring regions in Italy, provide 2 telling examples with
strikingly different endings. As of April 15, 2020, a total of 44,107
tests per million people have been performed in Veneto, which is
double the number of tests conducted in Lombardia (Fig. 1).
Indeed, in contrast to the neighboring region, Veneto adopted a
large-scale population screening model at the beginning of the
outbreak, allowing home isolation for a larger number of mild (or
asymptomatic) cases (85% vs 60% of active cases according to the
last estimates).4 This strategy may have avoided overwhelming the
health system, with a consequent positive impact on the case fatality
rate in Veneto, which is currently almost 3 times lower than that in
Lombardia.
In fact, in line with previous modeling predictions,5 Lombardia
did run out of intensive care beds at the end of March, resulting in
the need to transfer critical patients to other Italian regions or
European countries. Furthermore, between one-half and one-third
of the daily national deaths are still being recorded in this region at
this time.
At a time when Italy is facing its biggest challenge since World
War II, the ‘Veneto model’ indicates that early mass screening
for SARS-CoV-2 can make a positive difference, and it should be
recommended to other countries responding to the COVID-19
pandemic.
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